Borrowed from the Army’s fitness test, these moves build the kind of strength and conditioning that carries over to real life.

A NEW study from the Multicenter Osteoarthritis Study (MOST) has found that adults with weaker knee extensor muscles, particularly the quadriceps—are significantly more likely to experience worsening ...

LONDON — The Jets got beat up Sunday, and now, one of their best players may miss time. Wide receiver Garrett Wilson injured his knee in Sunday’s game and will undergo testing to see how serious it is ...

The continued approval of Forzinity is contingent upon verification and description of clinical benefit in a confirmatory trial. The Food and Drug Administration (FDA) has granted accelerated approval ...

Until now, Barth syndrome, a fatal genetic condition that affects the heart and muscles, was deemed untreatable. The first therapy has been greenlit by U.S. regulators, as it was able to improve ...

The FDA on Friday granted accelerated approval to elamipretide (Forzinity) as the first treatment for the ultra-rare Barth syndrome, which affects approximately 150 Americans. Elamipretide once-daily ...

NEEDHAM, Mass., Sept. 19, 2025 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a commercial-stage biotechnology company focused on the discovery, development and ...

The MarketWatch News Department was not involved in the creation of this content. NEEDHAM, Mass., Sept. 19, 2025 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a commercial ...

The key to healthy joints is often strengthening the muscles on either side of them. The key to healthy joints is often strengthening the muscles on either side of them. Credit... Supported by By Jen ...

The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for elamipretide in the treatment of Barth syndrome, a rare mitochondrial disease. We are ...